Allspring Global Investments Holdings LLC Boosts Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Allspring Global Investments Holdings LLC lifted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 32.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 104,253 shares of the medical instruments supplier's stock after acquiring an additional 25,626 shares during the period. Allspring Global Investments Holdings LLC owned 0.43% of ICU Medical worth $10,398,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Equitable Trust Co. lifted its position in shares of ICU Medical by 30.6% during the 4th quarter. Equitable Trust Co. now owns 4,142 shares of the medical instruments supplier's stock valued at $413,000 after acquiring an additional 970 shares during the period. New York State Teachers Retirement System lifted its position in shares of ICU Medical by 6.8% during the 4th quarter. New York State Teachers Retirement System now owns 27,566 shares of the medical instruments supplier's stock valued at $2,749,000 after acquiring an additional 1,761 shares during the period. Private Trust Co. NA lifted its position in shares of ICU Medical by 273.8% during the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier's stock valued at $120,000 after acquiring an additional 879 shares during the period. State of Alaska Department of Revenue lifted its position in shares of ICU Medical by 417.8% during the 4th quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier's stock valued at $1,244,000 after acquiring an additional 10,066 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of ICU Medical during the 4th quarter valued at $106,000. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Stock Down 0.5 %

Shares of NASDAQ ICUI traded down $0.45 during trading on Wednesday, hitting $95.88. The stock had a trading volume of 140,242 shares, compared to its average volume of 260,557. ICU Medical, Inc. has a 12 month low of $78.28 and a 12 month high of $212.43. The company has a debt-to-equity ratio of 0.74, a current ratio of 2.53 and a quick ratio of 1.06. The company has a market capitalization of $2.34 billion, a PE ratio of -77.95 and a beta of 0.69. The firm has a fifty day moving average of $102.46 and a two-hundred day moving average of $98.79.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.39. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. The firm had revenue of $587.86 million during the quarter, compared to analyst estimates of $564.77 million. As a group, equities research analysts forecast that ICU Medical, Inc. will post 3.52 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, KeyCorp upped their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the stock an "overweight" rating in a report on Wednesday, February 28th. One research analyst has rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $123.00.

Insider Transactions at ICU Medical

In other news, VP Daniel Woolson sold 791 shares of the company's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $98.27, for a total value of $77,731.57. Following the completion of the sale, the vice president now owns 13,980 shares in the company, valued at approximately $1,373,814.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other ICU Medical news, VP Daniel Woolson sold 791 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $98.27, for a total transaction of $77,731.57. Following the completion of the transaction, the vice president now owns 13,980 shares in the company, valued at $1,373,814.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 13,603 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The disclosure for this sale can be found here. Insiders sold a total of 24,262 shares of company stock worth $2,545,532 in the last quarter. 6.70% of the stock is currently owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.